IP Library Patent Application 15386958
Patent Application
App. No. 15/386,958

SYSTEMS AND METHODS FOR QUANTIFICATION OF CREATININE USING A CREATININE-PROTEIN CONJUGATE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/386,958
Abstract

A system for determining a level of creatinine in a sample includes a test strip system configured to receive a sample, the test strip system including a first lateral flow test strip and a meter configured to receive the test strip, wherein the meter is configured to read the test strip and detect a level of creatinine, wherein the first lateral flow test strip includes microparticles combined with a creatinine antibody.

Claims (40)

1 . A system for determining a level of creatinine in a sample, comprising:

a test strip system configured to receive a sample, the test strip system including a first lateral flow test strip; and

a meter configured to receive the test strip, wherein the meter is configured to read the test strip and detect a level of creatinine, wherein the first lateral flow test strip includes microparticles combined with a creatinine antibody.

2 . The system of claim 1 , wherein the first lateral flow test strip includes compounds to bind with the microparticles combined with the creatinine antibody, wherein the compounds are a creatinine-protein conjugate.

3 . The system of claim 2 , wherein the creatinine-protein conjugate is a creatinine BSA conjugate.

4 . The system of claim 1 , wherein the creatinine-protein conjugate includes a carrier protein selected from a group consisting of Human serum albumin, Keyhole limpet hemocyanin (KLH), and ovalbumin.

5 . The system of claim 3 , wherein the test strip system includes a sample pad oriented in line with an opening in a cartridge, the cartridge holding the sample pad and the first lateral flow test strip.

6 . The system of claim 5 , wherein the microparticles are fluorescent.

7 . The system of claim 5 , wherein the microparticles have reflective properties.

8 . The system of claim 5 , wherein the microparticles have properties that provide for the absorption of light.

9 . The system of claim 5 , further comprising a second lateral flow test strip, the second lateral flow test strip in communication with the sample pad, wherein the meter is configured to read the second lateral flow test strip and provide an indication of a second level of creatinine in the sample.

10 . The system of claim 9 , wherein the meter provides an estimation of a level of creatinine based on the first level of creatinine and the second level of creatinine.

11 . A test strip system for determining a level of creatinine in a sample, comprising:

a first lateral flow test strip, wherein the first lateral flow test strip includes microparticles combined with a creatinine antibody.

12 . The system of claim 11 , wherein the first lateral flow test strip includes compounds to bind with the microparticles combined with the creatinine antibody wherein the compounds are a creatinine-protein conjugate.

13 . The system of claim 12 , wherein the creatinine-protein conjugate is a creatinine BSA conjugate.

14 . The system of claim 12 , wherein the creatinine-protein conjugate includes a carrier protein selected from a group consisting of Human serum albumin, Keyhole limpet hemocyanin (KLH), and ovalbumin.

15 . The system of claim 13 , further comprising a sample pad oriented in line with an opening in a cartridge, the cartridge holding the sample pad and the first lateral flow test strip.

16 . The system of claim 14 , wherein the microparticles are fluorescent.

17 . The system of claim 14 , wherein the microparticles have reflective properties.

18 . The system of claim 14 , wherein the microparticles have properties that provide for the absorption of light.

19 . The system of claim 14 , further comprising a second lateral flow test strip, the second lateral flow test strip in communication with the sample pad, wherein the meter is configured to read the second lateral flow test strip and provide an indication of a second level of creatinine in the sample.

20 . A method of determining a level of creatinine in a sample comprising:

providing a first lateral flow test strip wherein the first lateral flow test strip includes microparticles combined with a creatinine antibody;

providing a meter configured to receive the test strip wherein the meter is configured to read the first lateral flow test strip and detect a level of creatinine;

placing a sample on the first lateral flow test strip;

laterally flowing the sample of the test strip; and

reading the test strip with the meter.

21 . The method of claim 20 , wherein the first lateral flow test strip includes compounds to bind with the microparticles combined with the creatinine antibody wherein the compounds are a creatinine-protein conjugate.

22 . The method of claim 21 , wherein the creatinine-protein conjugate is a creatinine BSA conjugate.

23 . The method of claim 21 , wherein the creatinine-protein conjugate includes a carrier protein selected from a group consisting of Human serum albumin, Keyhole limpet hemocyanin (KLH), and ovalbumin.

24 . The method of claim 22 , wherein the test strip system includes a sample pad oriented in line with an opening in a cartridge, the cartridge holding the sample pad and the first lateral flow test strip.

25 . The method of claim 24 , wherein the microparticles are fluorescent.

26 . The method of claim 24 , wherein the microparticles have reflective properties.

27 . The method of claim 24 , wherein the microparticles have properties that provide for the absorption of light.

28 . The method of claim 24 , further comprising:

providing a second lateral flow test strip, the second lateral flow test strip in communication with the sample pad; and

reading the second lateral flow test strip and providing an indication of a second level of creatinine in the sample.

29 . The method of claim 28 , further comprising:

providing an estimation of a level of creatinine based on the first level of creatinine and the second level of creatinine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2017
From: PATWARDHAN, ANIRUDDHA; JESSWEIN, RYAN; MOSKOWITZ, KEITH
To: POLYMER TECHNOLOGY SYSTEMS, INC.
Reel/Frame 041242/0713 →